Literature DB >> 27490488

IMAGING DIAGNOSIS-MAGNETIC RESONANCE IMAGING FEATURES OF A MULTIFOCAL OLIGODENDROGLIOMA IN THE SPINAL CORD AND BRAIN OF A DOG.

Amy E Schkeeper1, Rachel Moon1, Stephanie Shrader2, Jey W Koehler2, Daniel Linden1, Amanda R Taylor1.   

Abstract

An 8-year-old neutered male Toy Poodle was presented with chronic, progressive tetraparesis, and possible seizures. Magnetic resonance images demonstrated an extensive, T1 and T2 hyperintense contrast enhancing mass in the cervical spinal cord. Three nodules were present on the surface of the thalamus, with enhancement most evident on delayed images. A diagnosis of high-grade oligodendroglioma was confirmed with postmortem histopathology and immunohistochemical labeling. Oligodendroglioma should be considered as a differential for T1 hyperintense intraaxial or intramedullary lesions with contrast enhancement. If enhancement is not visualized on postcontrast images, delayed images may be beneficial.
© 2016 American College of Veterinary Radiology.

Entities:  

Keywords:  MRI; T1-weighted hyperintense; brain; oligodendroglioma; spinal cord

Mesh:

Year:  2016        PMID: 27490488     DOI: 10.1111/vru.12401

Source DB:  PubMed          Journal:  Vet Radiol Ultrasound        ISSN: 1058-8183            Impact factor:   1.363


  2 in total

1.  Diffuse meningeal oligodendrogliomatosis characterized by spinal intra-parenchymal nodules on magnetic resonance imaging in a dog.

Authors:  Céline Giron; Dominique Paquette; Déborah Culang; Monique Doré; Isabelle Masseau
Journal:  Can Vet J       Date:  2020-12       Impact factor: 1.008

2.  Clinical features, diagnosis, and survival analysis of dogs with glioma.

Authors:  Roberto José-López; Rodrigo Gutierrez-Quintana; Cristian de la Fuente; Edgar G Manzanilla; Anna Suñol; Dolors Pi Castro; Sonia Añor; Daniel Sánchez-Masian; Francisco Fernández-Flores; Emanuele Ricci; Katia Marioni-Henry; Joan Mascort; Lara A Matiasek; Kaspar Matiasek; Paul M Brennan; Martí Pumarola
Journal:  J Vet Intern Med       Date:  2021-06-12       Impact factor: 3.175

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.